CAS: 7790-53-6; Potassium Metaphosphate

上下游产品

pyrographite phosphoric acid ammonium dihydrogen phosphate potassium carbonate

专利信息

专利号:US-2004267028-A1
优先权日:2001-09-24
标题 :Preparation and use of pyrrole derivatives for treating obesity
发明人：SMITH ROGER A; KLUENDER HAROLD C; SU NING; LAVOIE RICO C; FAN JIANMEI
权利人:SMITH ROGER A; KLUENDER HAROLD C; SU NING; LAVOIE RICO C; FAN JIANMEI
摘要:This invention relates to pyrrole derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.

专利号:US-2025313471-A1
优先权日:2024-03-29
标题 :Mechanochemical reduction of phosphates as a sustainable route to phosphite salts and organophosphite compounds
发明人：LOEWE PAWEL; CUMMINS CHRISTOPHER C; TAAKILI RACHID; XIN (DECEASED) TIANSI
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Disclosed herein, among other things, are methods for the mechanochemical synthesis of phosphite salts and organophosphite compounds from phosphates, such as condensed phosphates.

专利号:US-4828849-A
优先权日:1988-01-14
标题 :Surfactant inhibition of dental plaque
发明人：LYNCH DONALD M; APPELBAUM BENJAMIN
权利人:WARNER LAMBERT CO
摘要:The invention provides an oral preparation or composition such as a mouthwash, mouthrinse, toothpaste and the like containing certain classes of surfactants which act to inhibit plaque formation by inhibiting the initial adherence of bacteria to the dentin surfaces and in the case of one class of surfactants additionally inhibiting the glucosyl transferase catalysis to prevent the synthesis of extracellular polysaccharides from sucrose. n The surfactants comprise substituted taurines, substituted isethionates and substituted hydroxy sultaines in which the substituents are long chain hydrocarbon radicals. The surfactants are employed in the aqueous-based oral compositions at concentrations between about 0.00001M to 0.1M to effect inhibition.

专利号:US-11738120-B1
优先权日:2022-04-14
标 题:Synthesis of taurolidine, purity profiles and polymorphs
发明人：BERRIOS REYES M
权利人:CORMEDIX INC
摘要:Improved methods for synthesizing taurolidine, improved compositions or formulations comprising taurolidine and methods for reducing an amount of impurities in taurolidine are provided herein, among other things. The taurolidine may be substantially free of impurities. The taurolidine may be a polymorph, for example, Polymorph A or Polymorph B. The composition or formulation may comprise Low-Molecular-Weight (LMW) Heparin.

专利号:US-7071207-B2
优先权日:2001-09-24
标题 :Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
发明人：SMITH ROGER A; O'CONNOR STEPHEN J; WONG WAI C; CHOI SOONGYU; KLUENDER HAROLD C; FAN JIANMEI; ZHANG ZHONGHUA; LAVOIE RICO C; PODLOGAR BRENT L
权利人:BAYER PHARMACEUTICALS CORP
摘要:This invention relates to 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.

专利号:WO-2004058727-A1
优先权日:2002-12-20
标题 :Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
发明人：CHEN YUANWEI; O'CONNOR STEPHEN JAMES; GUNN DAVID; NEWCOM JASON; CHEN JIANQING; YI LIN; ZHANG HAI-JUN; HUNYADI LASZLO MATYAS; NATERO REINA
权利人:BAYER PHARMACEUTICALS CORP; CHEN YUANWEI; O'CONNOR STEPHEN JAMES; GUNN DAVID; NEWCOM JASON; CHEN JIANQING; YI LIN; ZHANG HAI-JUN; HUNYADI LASZLO MATYAS; NATERO REINA
摘要:This invention relates to substituted 3,5-dihydro-4H-imidazol-4-ones compounds which are useful in the treatment of obesity and obesity-related disorders, and as weight-loss and weight-control agents. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.